Digital Course: Transitioning a Biobanking Effort with Scientific and Fiscal Responsibility

CONFERENCE SERIES: Biomarkers & Diagnostics 

Recorded at: Leaders in Biobanking Congress 

Order DVD2010 DVD Cover About this Product:
The scientific challenges that biobanks currently face is only half of the problem.  The integration of fiscal responsibility for the design, creation and implementation of both small and large biobanks is of paramount importance.  This digital course will address the practical operational issues from a scientific and fiscal perspective when creating, transitioning and managing a comprehensive biobanking and lab services program.  Tools will be provided to help scientists, managers and business units grow existing programs in a fiscally responsible manner without sacrificing science or sample quality.

About this Product:
1 Presentations
Over 49 Slides
130 Minutes
Individual Copy: $345
Site License: $1380

Agenda at a Glance: 

  • How to evaluate and implement new technologies both operationally and fiscally
  • How to build cost structures for comprehensive biobanking services
  • When and how to integrate automation without “breaking the bank”
  • How to evaluate storage environments to balance cost vs. stability
  • How to add services in a scientific and fiscally responsible manner
  • How to model your business “around” your science


Speaker Bio:
Andrew Brooks, Ph.D., Director of Operations, Rutgers University Cell and DNA Repository; Associate Professor, Genetics, Rutgers University
Andrew BrooksDr. Brooks is currently the Chief Operating Officer of the Rutgers University Cell and DNA Repository (RUCDR) and Director of the Bionomics Research and Technology Center (BRTC) at the Environmental and Occupational Health Science Institute of the University of Medicine and Dentistry of New Jersey. He is an Associate Professor of Environmental Medicine and Genetics at UMDNJ/Rutgers. Dr. Brooks is a molecular neuroscientist whose research focuses on deciphering the molecular mechanisms that underlie memory and learning. These studies investigate gene-environment interactions in the context of aging, neurodegenerative disease and neurotoxicant exposure. Dr. Brooks is a well-recognized genomicist and has been involved in the development and implementation of cutting edge molecular based technologies for nucleic acid and protein analyses.  He has worked to automate the RUCDR and build the service entity that provides high throughput sample management and analysis for DNA, RNA and protein-based technologies to hundreds of labs globally.

About the Conference:
Molecular advances in biomedical science require high-quality biospecimens (tissue, body fluid, or other material) which provide macromolecules (DNA/RNA, proteins, enzymes, etc.) that are used for diagnostic, therapeutic, and epidemiologic purposes, allowing researchers to better link molecular and clinical information. Today, biospecimen collections are used by multiple groups for varying aims from basic research through clinical trials. Investigators realize that the proper collection, processing, storage, and tracking of biospecimens are critical components of biomarker-related studies.

By Series:
By Region:

& Course Catalog

CHI Catalog 

Short Course DVDs